Market ExpansionAdding SI Joint and other products could enable Nevro to secure better contracts with larger health systems, expanding its market reach beyond being a single product company.
Product DevelopmentNevro will soon announce a product enhancement for iQ, called HFX AdaptiveAI, which is based on a comprehensive dataset of 100,000 patients and could revolutionize pain management.
Strategic ReviewNevro's management is considering various strategic options including partnerships, mergers, or a sale, which could significantly enhance the company's growth and shareholder value.